deCODE Homepage - www.decode.com deCODE's Therapeutic Pipeline From Genes to Drugs About deCODE genetics Investors - DCGN deCODE services

www.decodeme.com


Reykjavik, Iceland, November 16, 2007

Welcome to deCODE genetics

 

Reykjavik, November 16, 2007 Welcome to deCODE genetics To view webcast please click here Webcast to be held at 9 AM EST Please log in to the webcast 15 minutes prior to the scheduled start. For those unable to listen to the webcast because of company firewall or other issues a recording of the webcast will be available at approx 17:00 Friday November 16

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, integration of acquired businesses, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.


 



 




www.decode.comSitemapContact deCODE geneticsSubscribe to the deCODE mailing listLegal Notice